Latest News about AZN
Recent news which mentions AZN
From Benzinga
US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs
December 26, 2023
From Benzinga
AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies
December 26, 2023
From Benzinga
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
December 22, 2023
From Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
December 22, 2023
From Benzinga
These 3 Big Pharma Stocks Are Making Big Plays With AI
December 22, 2023
From Motley Fool
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
December 21, 2023
From Motley Fool
Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
December 20, 2023
From Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
From Benzinga
From Benzinga
Why Is Compugen (CGEN) Stock Up 189% Today?
December 19, 2023
From InvestorPlace
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
December 18, 2023
From Motley Fool
Health Care Company AstraZeneca Announces Acquisition of Icosavax
December 12, 2023
From Benzinga
Oracle's Falling, but You Won't Want to Miss This Soaring Biotech Stock
December 12, 2023
From Motley Fool
Why Is Icosavax (ICVX) Stock Up 46% Today?
December 12, 2023
From InvestorPlace
From InvestorPlace
From MarketWatch
From Benzinga
From Benzinga
AstraZeneca's Investigational Drug Shows Durable Clinical Benefit In Patients With Rare Blood Disease
December 11, 2023
Tickers
AZN
From Benzinga
Tickers
AZN
From Motley Fool
From MarketWatch
From Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
December 04, 2023
From Benzinga
Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
December 01, 2023
From Benzinga
AstraZeneca Stops Two Lokelma Late-Stage Trials After Evaluating Potential Benefits
December 01, 2023
Tickers
AZN
From Benzinga
Industry Comparison: Evaluating AstraZeneca Against Competitors In Pharmaceuticals Industry
November 27, 2023
Tickers
AZN
From Benzinga
Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant
November 22, 2023
Tickers
AZN
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.